rs754786373
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP5
The NM_001378457.1(DMXL2):c.7250G>A(p.Arg2417His) variant causes a missense change. The variant allele was found at a frequency of 0.0000217 in 1,613,218 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001378457.1 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 81Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- polyendocrine-polyneuropathy syndromeInheritance: AR, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- hearing loss, autosomal dominant 71Inheritance: AD, Unknown Classification: LIMITED Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DMXL2 | NM_001378457.1 | c.7250G>A | p.Arg2417His | missense_variant | Exon 29 of 44 | ENST00000560891.6 | NP_001365386.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151952Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000358 AC: 9AN: 251084 AF XY: 0.0000516 show subpopulations
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461266Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 726918 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151952Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74178 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hearing loss, autosomal dominant 71 Pathogenic:2
This variant occurred in heterozygosity in a patient with bilateral sensorineural hearing loss of onset <18 years within a single family, in a study of pediatric hearing loss conducted by the King Laboratory (Carlson RJ et al. JAMA-OtoHNS 2023). This patient’s family has no other history of hearing loss. This variant is a missense at a completely conserved site and is predicted to be damaging by multiple in-silico tools. As of January 2023, this variant has been reported to ClinVar as likely pathogenic and is found in 9 heterozygotes on gnomAD. Based on consistently predicted functional effect, literature evidence of pathogenicity, and goodness of fit of genotype to phenotype, we conclude that this variant is likely pathogenic. -
- -
not provided Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 2417 of the DMXL2 protein (p.Arg2417His). This variant is present in population databases (rs754786373, gnomAD 0.008%). This missense change has been observed in individual(s) with autosomal dominant non-syndromic hearing loss (PMID: 27657680). ClinVar contains an entry for this variant (Variation ID: 431430). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at